CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 6 of 6 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT01277627 Org: User:

Start: 01/31/11 End: - Due: -

Phase: N/A Priority: Normal

NCT ID: NCT00856804 Org: User:

Start: 03/31/09 End: 06/30/12 Due: 06/30/13

Phase: N/A Priority: Normal

NCT ID: NCT01908660 Org: User:

Start: 01/31/07 End: 10/31/15 Due: 10/31/16

Phase: N/A Priority: Normal

NCT ID: NCT02057003 Org: User:

Start: 01/31/12 End: 12/31/20 Due: 12/31/21

Phase: N/A Priority: Normal

NCT ID: NCT00546442 Org: User:

Start: 05/31/06 End: 01/31/07 Due: 01/31/08

Phase: N/A Priority: Normal

NCT ID: NCT02333292 Org: User:

Start: 12/31/14 End: 06/30/17 Due: 06/30/18

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Influence of Nevirapine on HCV Viral Load	NCT01277627	Valme University Hospital	user2@example.com	None	2011-01-31	-	-	-	-	2025-07-14
Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance	NCT00856804	Valme University Hospital	user2@example.com	None	2009-03-31	2012-06-30	2013-06-30	-	-	2025-07-14
Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions	NCT01908660	Valme University Hospital	user2@example.com	None	2007-01-31	2015-10-31	2016-10-31	-	-	2025-07-14
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients	NCT02057003	Valme University Hospital	user2@example.com	None	2012-01-31	2020-12-31	2021-12-31	-	-	2025-07-14
Treatment Insulin Resistence in HCV G-1 Patient	NCT00546442	Valme University Hospital	user2@example.com	None	2006-05-31	2007-01-31	2008-01-31	-	-	2025-07-14
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions	NCT02333292	Valme University Hospital	user2@example.com	None	2014-12-31	2017-06-30	2018-06-30	-	-	2025-07-14